13F-HR filed by Canaan Partners XI LLC
Canaan Partners XI LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-04-28, with 6 holding rows worth $240,162,000.
- Accession
- 0000950123-22-004344
- Filer
- CIK 1850694
- Filed
- 2022-04-28
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 6 entries on the cover page, a total value of $240,162,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $240,162,000 with VALUE read as thousands by filing date, 13F file number 028-21580. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 9,663,645 | $95,863,000 | thousands by filing date | |
| AEVA TECHNOLOGIES INC | 00835Q103 | COM | 18,485,197 | $79,948,000 | thousands by filing date | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 4,409,991 | $47,187,000 | thousands by filing date | |
| RALLYBIO CORP | 75120L100 | COM | 2,409,712 | $16,820,000 | thousands by filing date | |
| VECTIVBIO HLDG AG | H9060V101 | COM | 37,051 | $175,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 09077J107 | COM | 69,270 | $169,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-22-004344 | this filing | 2022-04-28 | acceptance time not in the bulk data set |